• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    More On PARD

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Poniard Pharmaceuticals, Inc. (PARD)

    -Other OTC
    0.12 0.00(0.00%) Jun 23, 3:14PM EDT
    Prev Close:0.12
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:1.86629
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.07 - 0.40
    Volume:0
    Avg Vol (3m):1,192
    Market Cap:7.20M
    P/E (ttm):N/A
    EPS (ttm):-3.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for PARD at this time.

    Comparison

    Symbol% ChgMkt Cap
    PARD 0.00%7.20M
    BMYDown 2.79%117.87B
    IMGNDown 5.72%272.55M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-11) :N/A
    Quarterly EPS Est (Mar-11) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback